Project Details
| Acronym | AIMS-2-TRIAL |
|---|---|
| Status | Active |
| Effective start/end date | 1/09/2021 → 31/05/2025 |
Collaborative partners
- King's College London (lead)
- Institut Pasteur
Funding
- F. Hoffmann-La Roche Ltd: £1,409,908.00
Autism Innovative Medicine Studies – 2 – Trials (Roche)
- Charman, Tony (Primary Investigator)
- Murphy, Declan (Co-Investigator)
Project: Research